Worldwide research trends on aristolochic acids (1957-2017): Suggestions for researchers.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
28
11
2018
accepted:
15
04
2019
entrez:
4
5
2019
pubmed:
3
5
2019
medline:
23
2
2020
Statut:
epublish
Résumé
Aristolochic acids and their derivatives are components of many traditional medicines that have been used for thousands of years, particularly in Asian countries. To study the trends of research into aristolochic acids and provide suggestions for future study, we performed the following work. In this paper, we performed a bibliometric analysis using CiteSpace and HistCite software. We reviewed the three phases of the development of aristolochic acids by using bibliometrics. In addition, we performed a longitudinal review of published review articles over 60 years: 1,217 articles and 189 review articles on the history of aristolochic acid research published between 1957 and 2017 were analyzed. The performances of relevant countries, institutions, and authors are presented; the evolutionary trends of different categories are revealed; the history of research into aristolochic acids is divided into three phases, each of which has unique characteristics; and a roadmap of the historical overview of aristolochic acid research is finally established. Finally, five pertinent suggestions for future research into aristolochic acid are offered: (1) The study of the antitumor efficacy of aristolochic acids is of value; (2) The immune activity of aristolochic acids should be explored further; (3) Researchers should perform a thorough overview of the discovery of naturally occurring aristolochic acids; (4) More efforts should be directed toward exploring the correlation between aristolochic acid mutational signature and various cancers; (5) Further efforts should be devoted to the research and review work related to analytical chemistry. Our study is expected to benefit researchers in shaping future research directions.
Identifiants
pubmed: 31048858
doi: 10.1371/journal.pone.0216135
pii: PONE-D-18-33729
pmc: PMC6497264
doi:
Substances chimiques
Aristolochic Acids
0
Types de publication
Historical Article
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216135Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Front Pharmacol. 2018 Mar 15;9:215
pubmed: 29599720
Nephrology (Carlton). 2004 Oct;9(5):313-8
pubmed: 15504145
Curr Opin Drug Discov Devel. 2009 Jan;12(1):141-8
pubmed: 19152223
Curr Pharm Des. 2007;13(28):2935-50
pubmed: 17979738
Carcinogenesis. 2007 Nov;28(11):2253-61
pubmed: 17434925
Cancer Res. 1996 May 1;56(9):2025-8
pubmed: 8616845
Adv Chronic Kidney Dis. 2005 Jul;12(3):261-75
pubmed: 16010641
Food Chem Toxicol. 2003 Jan;41(1):29-36
pubmed: 12453725
Arzneimittelforschung. 1974 Jan;24(1):52-4
pubmed: 4406110
Arch Int Pharmacodyn Ther. 1963 Oct 1;145:334-55
pubmed: 14071480
Nat Commun. 2014 Dec 15;5:5696
pubmed: 25526346
J Thorac Oncol. 2016 Jul;11(7):1040-50
pubmed: 27013405
J Urol. 2013 Jan;189(1):48-52
pubmed: 23164394
Carcinogenesis. 1997 May;18(5):1063-7
pubmed: 9163697
Oncogene. 2017 Jan 12;36(2):158-167
pubmed: 27270430
Nucleic Acids Res. 2010 Jan;38(1):339-52
pubmed: 19854934
J Ethnopharmacol. 2004 Oct;94(2-3):245-9
pubmed: 15325726
Adverse Drug React Toxicol Rev. 1991 Winter;10(4):189-208
pubmed: 1793770
J Formos Med Assoc. 2011 Mar;110(3):161-8
pubmed: 21497279
Nat Prod Rep. 2003 Dec;20(6):565-83
pubmed: 14700200
Curr Pharm Des. 2016;22(34):5270-5293
pubmed: 27339430
Carcinogenesis. 1990 Feb;11(2):313-9
pubmed: 2302759
Mol Med Rep. 2016 Oct;14(4):3243-50
pubmed: 27510522
Eur Urol. 2018 Jan;73(1):94-108
pubmed: 28803033
J Ethnopharmacol. 1993 May;39(1):1-29
pubmed: 8331959
Planta Med. 1975 Feb;27(1):68-71
pubmed: 1161879
Am J Kidney Dis. 1999 Jun;33(6):1011-7
pubmed: 10352187
Occup Environ Med. 2011 Apr;68(4):286-90
pubmed: 20935286
J Sep Sci. 2017 Jul;40(13):2791-2799
pubmed: 28520091
Planta Med. 1979 Apr;35(4):360-5
pubmed: 451055
J Org Chem. 1965 Nov;30(11):3792-800
pubmed: 5846158
Kidney Int. 2001 Jun;59(6):2164-73
pubmed: 11380818
J Ethnopharmacol. 1999 Feb;64(2):185-9
pubmed: 10197755
Evid Based Complement Alternat Med. 2013;2013:263757
pubmed: 23606874
J Ethnopharmacol. 2017 Jan 20;196:104-109
pubmed: 27915077
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8241-6
pubmed: 22493262
Lancet. 1993 Feb 13;341(8842):387-91
pubmed: 8094166
Br J Pharmacol. 2009 Aug;157(7):1128-41
pubmed: 19508399
Xenobiotica. 1987 Aug;17(8):981-91
pubmed: 3673113
Life Sci. 2004 Jan 9;74(8):935-68
pubmed: 14672753
Drug Discov Today. 2018 Mar;23(3):661-672
pubmed: 29330123
J Am Soc Nephrol. 2007 Nov;18(11):2817-23
pubmed: 17942951
Kidney Int. 1994 Jun;45(6):1680-8
pubmed: 7933816
Sci Transl Med. 2013 Aug 7;5(197):197ra102
pubmed: 23926200
Cancer Discov. 2017 Oct;7(10):1116-1135
pubmed: 28667006
Nutr Rev. 2016 Aug;74(8):475-89
pubmed: 27330144
Molecules. 2017 Sep 11;22(9):
pubmed: 28892002
Mutat Res. 1985 Jul;143(3):143-8
pubmed: 4010694
Carcinogenesis. 1988 Feb;9(2):297-303
pubmed: 3338114
Carcinogenesis. 2002 Apr;23(4):617-25
pubmed: 11960915
J Pharm Biomed Anal. 2011 Jun 25;55(4):744-57
pubmed: 21131153
Eur Urol. 2011 Jun;59(6):1026-31
pubmed: 21458152
Sci Transl Med. 2017 Oct 18;9(412):
pubmed: 29046434
Curr Med Chem. 2005;12(22):2625-41
pubmed: 16248818
J Natl Cancer Inst. 2010 Feb 3;102(3):179-86
pubmed: 20026811
J Ethnopharmacol. 2008 Sep 2;119(1):87-93
pubmed: 18582552
Nat Prod Rep. 2011 Jan;28(1):152-67
pubmed: 21127810
PLoS One. 2017 Feb 13;12(2):e0172128
pubmed: 28192519
Neuro Endocrinol Lett. 2011;32 Suppl 1:121-30
pubmed: 22167220
J Am Soc Nephrol. 2002 Feb;13(2):431-6
pubmed: 11805172
Eur J Biochem. 1967 Mar;1(1):70-2
pubmed: 6059349
Int J Cancer. 2015 Jun 15;136(12):2967-72
pubmed: 25403517
Biomed Res Int. 2013;2013:153045
pubmed: 24171158
Genome Med. 2015 Apr 28;7(1):38
pubmed: 26015808
J Org Chem. 1968 Oct;33(10):3735-8
pubmed: 5743777
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Dec 5;812(1-2):23-33
pubmed: 15556486
Nucleic Acids Res. 2012 Mar;40(6):2494-505
pubmed: 22121226
Nucleic Acids Res. 2012 Mar;40(6):2759-70
pubmed: 22121223
Sci Transl Med. 2013 Aug 7;5(197):197ra101
pubmed: 23926199
Nat Biotechnol. 2006 Sep;24(9):1162-9
pubmed: 17061323
Lancet. 2001 Nov 3;358(9292):1515-6
pubmed: 11705569
N Engl J Med. 2000 Jun 8;342(23):1686-92
pubmed: 10841870
Lancet. 2017 Oct 21;390(10105):1888-1917
pubmed: 28434650
Lancet. 2013 Jul 20;382(9888):260-72
pubmed: 23727169
Kidney Int. 2005 May;67(5):1797-805
pubmed: 15840026
J Appl Toxicol. 2015 Dec;35(12):1433-7
pubmed: 26152912
Nat Commun. 2014 Oct 29;5:5135
pubmed: 25351205
Int J Mol Sci. 2017 Oct 14;18(10):
pubmed: 29036902
Mutagenesis. 2002 Jul;17(4):265-77
pubmed: 12110620
Nat Prod Rep. 2014 May;31(5):676-93
pubmed: 24691743
Cancer Lett. 2013 Jun 28;334(1):5-9
pubmed: 23178450
PLoS Genet. 2012;8(4):e1002657
pubmed: 22511890
Nucleic Acids Res. 2015 Sep 3;43(15):7388-97
pubmed: 26175048
Planta Med. 2010 Dec;76(17):2012-8
pubmed: 21077025
Am J Kidney Dis. 2000 Feb;35(2):313-8
pubmed: 10676733
Chem Res Toxicol. 2001 Aug;14(8):1128-37
pubmed: 11511187
Forensic Sci Int. 2010 Jun 15;199(1-3):e5-7
pubmed: 20193994
Am J Nephrol. 2006;26(1):1-11
pubmed: 16391464
Chem Res Toxicol. 2014 Mar 17;27(3):356-66
pubmed: 24437709